Therapy Areas
25 May 2018 - - Melbourne, Australia-based allergy immunotherapy company Prota Therapeutics Pty Ltd has achieved full enrollment in the multicentre Phase 2b clinical trial investigating the effectiveness of its Probiotic and Peanut Oral Immunotherapy...
25 May 2018 - - Paris, France-based biotechnology company PathoQuest has commenced enrollment of adult and pediatric patients in a medico-economic study of its metagenomic iDTECT Blood test for infectious bacterial and viral pathogens in immunocompro...
25 May 2018 - - Cambridge, Massachusetts-based genome editing company LogicBio Therapeutics, Inc. has appointed Dean Falb, Ph.D. as chief scientific officer (CSO), the company said.
Falb has more than 20 years of drug discovery and development...
25 May 2018 - - Tokyo, Japan-based pharmaceutical company Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) has presented full results from HAVEN 3 and HAVEN 4, studies evaluating its hemophilia A treatment Hemlibra (emicizumab), at the World Federation ...
25 May 2018 - - Mumbai, India-based specialty generic company Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA, BSE: 524715) subsidiary, Princeton, New Jersey-based SPII, has received approval from the US Food and Drug Administration for Yonsa (abi...
25 May 2018 - - Cambridge, Massachusetts-based biotherapeutic company Sesen Bio (NASDAQ: SESN) has seen positive, three-month data from its ongoing Phase 3 VISTA trial of Vicinium for the treatment of patients with1 high-grade non-muscle invasive bla...
25 May 2018 - - New York, New York-based biopharmaceutical and healthcare products specialist Pfizer Inc. (NYSE: PFE) has released results from a study analyzing real-world effectiveness data that found Prevnar 13 (pneumococcal 13-valent conjugate va...